Oxaliplatin/capecitabine or carboplatin/paclitaxel-based preoperative chemoradiation for resectable oesophageal adenocarcinoma (NeoSCOPE): Long-term results of a randomised controlled trial

S. Mukherjee, C. Hurt*, G. Radhakrishna, S. Gwynne, A. Bateman, S. Gollins, M.A. Hawkins, J. Canham, H.I. Grabsch, S. Falk, R.A. Sharma, R. Ray, R. Roy, C. Cox, N. Maynard, L. Nixon, D.J. Sebag-Montefiore, T. Maughan, G.O. Griffiths, T.D.L. Crosby

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)153-161
Number of pages9
JournalEuropean Journal of Cancer
Volume153
DOIs
Publication statusPublished - 1 Aug 2021

Keywords

  • Randomised controlled trial
  • Neoadjuvant chemoradiotherapy
  • Surgery
  • Survival
  • Oesophageal cancer
  • NEOADJUVANT CHEMORADIOTHERAPY
  • PERIOPERATIVE CHEMOTHERAPY
  • SURGERY
  • CANCER

Cite this